Institutional Ownership Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 719,693 shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Trv Gp Ii, LLC
Boston, MA |
Nov 03, 2022 Q3 2022 |
572,829
shares
|
$0
100.0% of portfolio
|
Q3 2022
Reduced 57.5%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
132,115
shares
|
$0
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Frontier Wealth Management LLC
Kansas City, MO |
Aug 12, 2022 Q2 2022 |
13,099
shares
|
$0
0.0% of portfolio
|
Q1 2021
Reduced 51.66%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
1,650
shares
|
$0
0.0% of portfolio
|
Q2 2020
Added 28.13%
|